EKF Diagnostics, the global in vitro diagnostics company, has published an Educational Guide which provides a quick overview of capillary blood sampling best practice. It aims to help healthcare ...
MeMed Severity™ has received FDA Breakthrough Device Designation as a host-response test designed to predict severe outcomes up to 72 hours and mortality 14 days in advance in patients with acute ...
A new needle-free blood test, TAP, launched by UHMBT NHS Trust, transforms care for patients with learning disabilities or needle phobia ...
New data suggest that blood glucose monitoring systems that rely on capillary samples may not be as accurate as arterial or venous sampling when used in patients receiving intensive medical ...
Variation in CGM bias by postprandial test, with glycemic index for commercial fruit smoothie higher with CGM versus capillary sampling. (HealthDay News) — Continuous glucose monitoring (CGM) can ...
EKF Diagnostics, the global in vitro diagnostics company, has published an Educational Guide which provides a quick overview of capillary blood sampling best practice. It aims to help health care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results